Chueajedton, K., Chueaiphuk, C., Inpad, J., Kumphune, S., Kaewkong, W., Surangkul, D., Sawanyawisuth, K., Cha’on, U., Phimsen, S. (2026). Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms. PLoS ONE. https://doi.org/10.1371/journal.pone.0340763